Seaport Therapeutics, Inc. $SPTX Shares Newly Acquired by State Street Corp

State Street Corp has acquired 66,650 shares of Seaport Therapeutics (NASDAQ:SPTX) worth approximately $1.45 million, representing a 0.12% stake in the company. Other institutional investors have also initiated positions. Despite a mixed analyst sentiment, with a consensus "Moderate Buy" rating and a price target of $38.57 against its current price of $21.52, Seaport Therapeutics reported a Q2 loss of $1.78 per share, missing consensus estimates.